Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort.

Antibodies (Basel) · 2026 · PMC13010646 · PMID 41874030

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, among mutated cases, subset #4 was significantly over-represented in the O-CLL1 cohort ( p < 0.01), whereas other mutated subsets (excluding subset #2) were not observed in O-CLL1, although the difference compared with CTR did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.